Board of Directors

2009-2010

• Robert Schotzinger, Chairman;
  CEO, Viamet Pharmaceuticals
• Charles Hamner, President Emeritus
• Tim Gupton, Treasurer
  Partner, Hughes Pittman & Gupton, LP
• Karen Albritton, President, CapStrat
• Esther Alegria, Director of Corporate Relations, Biogen Idec
• Peyton Anderson, CEO, Affinergy
• Lou Arp, Vice President Production Operations, Eisai
• Jonathan Bryant, Managing Director, BASF Plant Science LCC
• Dennis Burns, Managing Partner, TCG Group/Curasan, LLC
• Chris Capel, Partner, Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.
• Jeffrey Collins, Executive in Residence, Pappas Ventures
• Terry Costello, President & COO, Yonkers Industries
• Ed Field, President, Aldagen
• Dr. Charles Goldstein, Vice President Research & Director, BD Technologies
• Tim Gupton, Partner, Hughes Pittman & Gupton, LP
• Matthew Jennings
• Kenneth Lee, General Partner, Hatteras BioCapital, LLC
• Michael Luther, President, David H. Murdock Research Institute
• David Miller, Director, R&D Policy, GlaxoSmithKline
• Adam Monroe, President, Novozymes North America, Inc.
• Alan Musso, Vice President and CFO, Targacept, Inc.
• Crawford Pounds, Partner, PricewaterhouseCoopers
• Russ Read, Executive Director, National Center for the Biotechnology Workforce, Forsyth Technical Community College
• John Russell, Partner, K & L Gates
• Robert Schotzinger, CEO, Viamet
• Dr. Thomas Staab, Chief Financial Officer, Inspire Pharmaceuticals
• Susan Thomason, Executive Director Global Business Development, NovaQuest, Quintiles Transnational
• Norris Tolson, President and CEO North Carolina Biotechnology Center
• Jan Turek, President and CEO, Biolex Therapeutics
• Eric Ward, President, Cropsolution
• Mark Weedon, BWA Consulting